Characterization of viridans group streptococci from endophthalmitis
眼内炎草绿色链球菌的特征
基本信息
- 批准号:10057004
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Amino Acid SequenceAntibioticsBacteriaBacterial ProteinsBacteriologyBioinformaticsCase StudyClinicalCollectionDeletion MutagenesisDevelopmentDiseaseEndophthalmitisEnzymesErythrocytesEtiologyEyeEye InfectionsFutureGenbankGene ExpressionGenesGeneticGenomeGenomicsGenus staphylococcusGrowthHealthHeterogeneityHorizontal Gene TransferHumanIn VitroInfectionInjectionsInvestigationKineticsKnowledgeLeadLiteratureMiningOligonucleotide PrimersOperative Surgical ProceduresOral cavityOrganismOryctolagus cuniculusOutcomePathogenesisPatientsPeptide HydrolasesProcessProteinsRecombinant ProteinsRecombinantsResearchResistanceRoleSequence AnalysisSheepStreptococcusStreptococcus Viridans GroupStreptococcus anginosusStreptococcus gordoniiStreptococcus mitisStreptococcus mutansStreptococcus oralisStreptococcus sanguisStructure of retinal pigment epitheliumSubstrate SpecificityTestingTranslatingTraumaVariantVirulenceVirulence FactorsVirulentVisualVitreous humorbacterial endophthalmitiscomparativecytokineepidemiology studyexperimental studyextracellulargenome analysisgenome sequencingin vivoinhibitor/antagonistnormal microbiotaoral commensaloral pathogenoutcome forecastpan-genomeprotein degradationprotein purificationtherapeutic developmenttherapy developmenttranscriptometranscriptome sequencingtranscriptomicswhole genome
项目摘要
Project Summary/Abstract
The viridans streptococci are classically considered oral commensals with cariogenic potential; however, these
bacteria are also listed among the most common species that cause bacterial endophthalmitis. Exogenous
bacterial endophthalmitis can occur following trauma, ocular surgery, or ocular injections. Antibiotics are used
to treat this disease, however, antibiotics are only able to kill the bacteria and do not ameliorate the damage to
the eye. Streptococcal species in particular are associated with very poor visual outcomes; despite treatment,
evisceration or enucleation commonly occur. The immediate objective of this application is to characterize
endophthalmitis strains of the viridans streptococci and identify their virulence factors. This objective is
intended to initiate study into the broader, long-term objectives of determining the mechanisms of pathogenesis
of this important group of species and identify potential targets for future therapies. Two major aims are
proposed: 1) to investigate the role of bacterial protease HtrA in endophthalmitis and determine its vitreous and
bacterial protein substrates, and 2) to analyze the pangenome and virulence transcriptome of endophthalmitis-
causing strains. The first aim will be tested by function analysis of recombinant HtrA variants cloned from the
viridans strains and by deletion mutagenesis of htrA from htrA-positive strains, as well as genetic addition of
htrA to htrA-negative strains. The second aim will employ whole genome sequencing of 21 strains followed by
bioinformatics pangenome analysis to identify conserved genes across the collection, and RNA-seq in vivo and
in vitro to determine the virulence transcriptome of this group of species. Accomplishment of these aims will
springboard the identification of key factors involved in ocular infection by these species. This research is
expected to benefit patient ocular health in the long-term because the knowledge to be gained can aid future
therapeutic development.
项目概要/摘要
草绿色链球菌通常被认为是具有致龋潜力的口腔共生菌。然而,这些
细菌也被列为引起细菌性眼内炎的最常见物种之一。外源性
细菌性眼内炎可能发生在外伤、眼部手术或眼部注射后。使用抗生素
然而,为了治疗这种疾病,抗生素只能杀死细菌,并不能改善对身体的损害。
眼睛。特别是链球菌物种与非常差的视力结果有关;尽管接受治疗,
经常发生内脏或去核。该应用程序的直接目标是表征
草绿色链球菌眼内炎菌株并鉴定其毒力因子。这个目标是
旨在启动研究以确定发病机制的更广泛、长期的目标
对这一重要物种进行研究,并确定未来治疗的潜在目标。两个主要目标是
提出:1)研究细菌蛋白酶HtrA在眼内炎中的作用并确定其玻璃体和
细菌蛋白底物,2) 分析眼内炎的全基因组和毒力转录组-
造成紧张。第一个目标将通过从克隆的重组 HtrA 变体的功能分析来测试
草绿色菌株,并通过 htrA 阳性菌株中 htrA 的缺失诱变,以及基因添加
htrA 至 htrA 阴性菌株。第二个目标是对 21 个菌株进行全基因组测序,然后
生物信息学泛基因组分析,以识别整个集合中的保守基因,以及体内和体内的RNA-seq
体外测定这组物种的毒力转录组。这些目标的实现将
确定与这些物种眼部感染有关的关键因素。这项研究是
预计将长期有益于患者的眼部健康,因为获得的知识可以帮助未来
治疗的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARY E MARQUART其他文献
MARY E MARQUART的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARY E MARQUART', 18)}}的其他基金
Characterization of viridans group streptococci from endophthalmitis
眼内炎草绿色链球菌的特征
- 批准号:
10245289 - 财政年份:2020
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
7494191 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
7351809 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
7777295 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
7583883 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
7210967 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Streptococcus pneumoniae ocular pathogenesis and therapy
肺炎链球菌眼部发病机制及治疗
- 批准号:
8035361 - 财政年份:2007
- 资助金额:
$ 19.38万 - 项目类别:
Pseudomonas proteases as ocular virulence factors
假单胞菌蛋白酶作为眼部毒力因子
- 批准号:
6525059 - 财政年份:2002
- 资助金额:
$ 19.38万 - 项目类别:
Pseudomonas proteases as ocular virulence factors
假单胞菌蛋白酶作为眼部毒力因子
- 批准号:
6404863 - 财政年份:2001
- 资助金额:
$ 19.38万 - 项目类别:
DETECTION OF HSV1 DNA IN TEARS--PROOF OF REACTIVATION
眼泪中 HSV1 DNA 的检测——重新激活的证据
- 批准号:
6012684 - 财政年份:1999
- 资助金额:
$ 19.38万 - 项目类别:
相似国自然基金
抗生素废水处理活性污泥中核心黏细菌资源的发掘及其生态功能研究
- 批准号:32300090
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微藻-细菌协同降解抗生素及其共适应机制
- 批准号:42377367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
靶向铜绿假单胞菌FpvA蛋白的铁载体偶联抗生素克服细菌耐药性及作用机制研究
- 批准号:82304313
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微塑料与β-内酰胺类抗生素联合暴露对耐药细菌胞外DNA生物转化的影响机制及其风险预测
- 批准号:52370202
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
色球藻—细菌共生体系降解抗生素同时提升产油性能的机理研究
- 批准号:22376123
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Cytotoxicity and function of incomplete proteins
不完整蛋白质的细胞毒性和功能
- 批准号:
10570685 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Leveraging evolutionary analyses and machine learning to discover multiscale molecular features associated with antibiotic resistance
利用进化分析和机器学习发现与抗生素耐药性相关的多尺度分子特征
- 批准号:
10658686 - 财政年份:2023
- 资助金额:
$ 19.38万 - 项目类别:
Antibiotic tolerance: membraneless organelles and autolysin regulation
抗生素耐受:无膜细胞器和自溶素调节
- 批准号:
10333641 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
Advancing ribosome-targeting antibacterial peptides with a unique mechanism of action
以独特的作用机制推进核糖体靶向抗菌肽
- 批准号:
10443921 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别:
VLP-based Vaccines for Targeting Staphylococcus Aureus β-barrel Toxins
基于 VLP 的针对金黄色葡萄球菌 β 桶毒素的疫苗
- 批准号:
10538909 - 财政年份:2022
- 资助金额:
$ 19.38万 - 项目类别: